![3-Methyl[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid - chemical structure image](https://media.scbt.com/product/3-methyl1-2-4triazolo4-3-apyridine-8-carboxylic-acid-structure_22_94_b_229439.jpg)
![3-Methyl[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid - chemical structure image](https://media.scbt.com/product/3-methyl1-2-4triazolo4-3-apyridine-8-carboxylic-acid-structure_22_94_t_229439.jpg "Molecular structure of 3-Methyl[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid")
Molecular structure of 3-Methyl[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid
3-Methyl[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid
Molecular Weight:
177.16
Molecular Formula:
C8H7N3O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Safety Information
SDS & Certificate of Analysis
AH-6809 is a prostaglandin E2 receptor antagonist. The compound has been reported to antagonize the anti-aggregatory activity of BW245C, 9 alpha, 11 beta-PGF2, and PGD2. Mouse prostanoid receptor studies reveal that AH-6809 antagonizes the EP1 and EP2 receptors, and does not bind to the EP4 receptor. AH-6809 may act to also act on DP1. Both EP1 and DP1 receptors induce and elevate intracellular calcium levels, and have the potential to influence the chloride secretory response. Additionally, studies indicate that AH-6809 is a PGE2 antagonist and that it has a more potent inhibitor than Butaprost (sc-221387), and has been used to study the PAR2 receptor. AH-6809 is an inhibitor of DP2 and EP3.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3-Methyl[1,2,4]triazolo[4,3-a]pyridine-8-carboxylic acid, 500 mg | sc-313419 | 500 mg | $450.00 |